Cyclosporine and bone mass

Clinical and Experimental Rheumatology

Volumn 18, Issue 5 SUPPL. 21, 2000, Pages

  Sambrook, P N ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bone density; Cyclosporine; Fracture; Osteoporosis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A;

BONE DENSITY; BONE DISEASE; BONE MASS; BONE TURNOVER; CALCIUM ABSORPTION; CALCIUM BALANCE; CALCIUM TRANSPORT; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FRACTURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; URINARY EXCRETION;

EID: 0033769042     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Fracture after cardiac transplantation: A prospective longitudinal study
2. Cyclopsorine A and prednisone-asociated osteoporosis in heart transplant recipients
3. Reduced bone mineral density in men and women with allogeneic bone marrow transplantation
4. Cyclosporin A in vivo produces severe osteopenia in the rat: Effect of dose and duration of administration
5. Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo
6. Different effects of cyclosporin A on bone remodeling in young and adult rats
7. Utilization of cyclosporine H to elucidate the possible mechanisms of cyclosporine A-induced osteopenia in the rat
8. Skeletal effects of low-dose cyclosporin A in aged male rats: Lack of relationship to serum testosterone levels
9. The role of testosterone in cyclosporine-induced osteopenia
10. T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia
11. Alendronate prevents cyclosporin A-induced osteopenia in the rat
12. Raloxifene analog (LY117018 HCL) ameliorates cyclosporin A-induced osteopenia in oophorectomized rats
13. Bone histology in renal transplant patients receiving cyclosporine
14. Rapid loss of vertebral mineral density after renal transplantation
15. Missing impact of cyclosporine on renal transplant recipients
16. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation
17. Mechanisms of bone loss after cardiac transplantation
18. Mechanisms of rapid bone loss following cardiac transplantation
19. Monitoring of bone metabolism after bone marrow transplantation by measuring two different markers of bone turnover
20. Bone loss in long-term renal transplantation: Histopathology and densitometry analysis
21. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation
22. Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: A prospective study
23. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis
24. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells
25. Cyclosporin A and glucorticoids inhibit osteoprotogerin production in human osteoblastic and coronary artery smooth muscle cells: Potential mechanisms of post-transplant osteoporosis and vascular disease
26. The use of cyclosporin A emulsion in rheumatoid arthritis: Conclusions of an international review
27. Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine - Results of a 48 week multicenter study comparing low dose cyclosporine with placebo
28. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A
29. Long term cyclosporin continuation rates in rheumatoid arthritis patients
30. Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy